World Menopause Day – 18th October 2022 with BMS Banner

World Menopause Day – 18th October 2022 with BMS

Categories: , , , ,

The British Menopause Society are continuing the conversation around Menopause.

The menopause has gone mainstream and after the deafening silence surrounding it for so long, that change is very welcome. The recent influx of information and misinformation can however be overwhelming and confusing and there is no ‘one size fits all’ solution.

For World Menopause Day 2022, the British Menopause Society has partnered with ITN Productions Industry News to produce a news-style programme ‘Menopause: Continuing the Conversation’ to cut through the noise to give straight talking, clear guidance and advice from BMS menopause specialists, healthcare professionals and BMS members, with information from industry experts, providing support for women to recognise and improve their symptoms.

Hosted by Louise Minchin, it will feature expert interviews, news items and reporter-led sponsored editorial profiles from leading organisations filmed on location.

The programme will launch on World Menopause Day, 18 October 2022

Hosted by Louise Minchin:

‘Menopause: Continuing the Conversation’

 

 

 

Latest News


In Australia, is Addyi (Flibanserin) available or what is available? In Australia, is Addyi (Flibanserin) available or what is available?

 Australia Leads the Way in Androgen Treatment for Women with HSDD While the US-approved drug flibanserin offers limited benefit for Hypoactive Sexual Desire Disorder (HSDD), it’s… Continue Reading →

How Satisfied are you with Your Sex Life? How Satisfied are you with Your Sex Life?

Let’s Talk About Sexual Satisfaction—It Matters More Than You Think Did you know that 4 in 10 women experience sexual concerns during mid-life? Yet many suffer… Continue Reading →

MHRA approves testosterone cream for UK postmenopausal women MHRA approves testosterone cream for UK postmenopausal women

  MHRA approves testosterone cream for UK postmenopausal women   12 August 2025 Perth, Australia and Guildford, England:   Lawley Pharmaceuticals and its commercial… Continue Reading →